3D Printing of Pharmaceuticals and Drug Delivery Devices |
Autore | Lamprou Dimitrios A |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (436 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
digital pharmacy
fused deposition modeling 3D printing modified drug release personalized medicines telemedicine three dimensional printing additive manufacturing 3D printed drug products printlets personalised medicines personalized pharmaceuticals multiple units spheroids beads acetaminophen 3D printing fused filament fabrication lignin antioxidant materials wound dressing modified release filament extrusion fused layer modeling theophylline high API load three-dimensional printing fixed-dose combinations tablets multiple-layer dosage forms stereolithography vat polymerisation fused deposition modeling polylactic acid chemical modification MTT assay biofilm formation warfarin semisolid extrusion 3D printing inkjet printing orodispersible film oral powder pediatric hospital pharmacy personalized medicine on-demand manufacturing drug delivery micromedicine drug development micro-swimmer micro-implant oral dosages microneedle high-precision targeting controlled release geometry resolution feature size release profile vascularization digital light processing technology neural networks optimization prediction FMD pregabalin gastric floating complex structures patient-specific structural design gums Fused Deposition Modeling 3D Printing processing parameters pharmaceutical quality control hot-melt extrusion solid dosage forms 3D printed oral dosage forms sustained drug release tablets photopolymerization paracetamol (acetaminophen) aspirin (acetylsalicylic acid) amorphous solid dispersion poor solubility fixed dose combination stencil printing pharmacoprinting orodispersible discs orodisperible films floating systems pulsatile release chronotherapeutic delivery wound-healing 3D bio-printing pectin propolis cyclodextrin 3D bio-inks fused deposition modelling extrusion vaginal meshes mechanical properties drug release anti-infective devices pelvic organ prolapse stress urinary incontinence gastro-retentive floating system dissolution kinetics implantable devices subcutaneous biodegradable prolonged drug delivery polymers pharmaceuticals extrusion-based 3D printing fused deposition modeling (FDM) pressure-assisted microsyringe (PAM) materials process 3D bioprinting polymeric ink pseudo-bone implantable scaffold computer-aided design (CAD) design bioprinting computer-aided design (CAD) pharmaceutics |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557780703321 |
Lamprou Dimitrios A | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer Nanomedicine |
Autore | Hoskins Clare |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (510 p.) |
Soggetto topico | Technology: general issues |
Soggetto non controllato |
antibody drug conjugate (ADC)
PD-L1 tumor spheroid disruption immune modulation doxorubicin graphene oxide adsorption cathepsin D cathepsin L anti-metastatic enzyme cancer therapy nanoparticles targeted delivery system siRNA osteopontin mammary carcinoma mesenchymal stem cells (MSCs) TAT peptide PLGA paclitaxel nano-engineered MSCs orthotopic lung tumor model intracranial glioma immunotherapy CPMV viral nanoparticles in situ vaccine albumin nanoparticles microbubble ultrasound theranostics hepatocellular carcinoma VX2 tumor intra-arterial chemotherapy lung cancer nanomedicine clinical status cancer therapy breast cancer cell signaling active targeting passive targeting EPR effect oncogenes nanoparticle drug delivery ligand tumor targeting biodistribution Mesoporous silica nanoparticle drug delivery system target treatment lanthanide metal hyaluronic acid hyaluronidase drug combination everolimus dual-targeting magnetic nanoparticles monoclonal antibodies nanostructured lipid carrier platelet membrane biomimicry plasmonic photothermal therapy gold nanorods surgery bleeding dogs cats stimuli-responsive DOX SN38 CSCs single-walled carbon nanotubes chirality separation NASH drug-gene delivery near IR hyperspectral imaging plasmonics copper VEGF glioblastoma differentiated neuroblastoma peptidomimetics real-time quantitative polymerase chain reaction (qPCR) actin combinatorial therapy anticancer and antibacterial activity temoporfin drug-in-cyclodextrin-in-liposome hybrid nanoparticles multicellular tumor spheroids cyclodextrins photodynamic therapy article yet reasonably common within the subject discipline antitumor strategy biomimetic core–shell nanoparticles NK cell-derived exosomes folate receptor albumin nanoparticle microfluidic cabazitaxel polydopamine nanoparticles size cytotoxicity iron affinity FA-DABA-SMA self-assembly oncogenic proteins intracellular disruption folic receptor alpha pancreatic cancer parvifloron D albumin erlotinib photodynamic therapy lipid nanoparticles tumor vectorization verteporfin ovarian carcinomatosis spheroids integrin RGD peptide cancer diagnosis radiotherapy hyperthermia therapy biomimetic nanocarrier membrane-wrapped cancer targeted delivery photothermal therapy imaging cancer nanomedicine tumor microenvironment nano–bio interactions clinical translation magnetic nanowires magnetic hyperthermia magnetic actuation magnetic drug targeting titanate nanotubes gold nanoparticles vectorization colloidal stability docetaxel prostate cancer mangiferin anti-topoisomerase activity extracellular vesicles exosomes chemico-physical functionalization loading translational medicine nanotechnology: bioengineering anacardic acid mitoxantrone targeted drug delivery liposomes melanoma apoptosis ascorbic acid angiogenesis epithelial-to-mesenchymal transition hypoxia immunosuppression metabolism nanotherapeutics tumour microenvironment DNA origami liposome remote loading acute toxicity organoids magnetic silica-coated iron oxide nanochains photothermal treatment hyperthermia collagen cellular microenvironment lymphadenectomy magnetometer sentinel lymph node dissection SPION superparamagnetic iron oxide nanoparticles Vδ2 T cells zoledronic acid polymeric nanoconstruct anti-tumor immunity colorectal carcinoma β-cyclodextrin nanosponges BALB-neuT mice brain tumours glioma blood brain barrier polymeric nanoparticles PEGylation dioleoylphosphatidylethanolamine poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer folate oxidation-sensitive release cellular interaction in vitro anti-cancer activity triple negative breast cancer organotin mesoporous silica nanoparticles MDA-MB-231 theranostic nanomaterials nanobiotechnology molecular imaging nanosystems nanomicelles ovarian cancer tumour targeting chemotherapeutics riboflavin vitamin B2 nanomedicines secondary structure mixed micelle pH responsive targeted therapy anti-cancer shear stress flow in vitro therapeutics diagnostics Immunotherapy |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557114703321 |
Hoskins Clare | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes |
Autore | Ylostalo Joni H |
Pubbl/distr/stampa | Basel, : MDPI Books, 2022 |
Descrizione fisica | 1 electronic resource (204 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
cell therapy
immunomodulation polyunsaturated fatty acid CD206 phagocytosis mesenchymal stem cells Vadadustat AKB-6548 preconditioning priming secretome chemotaxis Wharton’s jelly mesenchymal stem cells umbilical cord oxygen conditions secretory profile neuroprotection mesenchymal stromal cells 3D culture neurospheres spheroids pluripotency neural quiescence mesothelioma malignant pleural mesothelioma (MPM) liver cirrhosis placenta-derived mesenchymal stem cells WKYMVm combination therapy iPSC-derived MSCs iMSC secretome pre-conditioning angiogenesis IFN-γ hypoxia potentiation of iMSC efficacy nanofiber-hydrogel composite spinal cord injury inflammation macrophages secondary injury astrocytes axon growth adipose tissue-derived stem cells (ASCs) autophagy rapamycin 3-methyladenine immunosuppression exosome engineered cardiac patches adipose-derived stem cell paracrine potential osteogenic differentiation hepatocyte growth factor fibroblast growth factor 2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Enhancing Mesenchymal Stem Cells |
Record Nr. | UNINA-9910595079403321 |
Ylostalo Joni H | ||
Basel, : MDPI Books, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside |
Autore | Tagit Oya |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (296 p.) |
Soggetto topico |
Technology: general issues
History of engineering & technology Materials science |
Soggetto non controllato |
poly(lactic-co-glycolic acid) (PLGA)
blood–brain barrier (BBB) current Good Manufacturing Practice (cGMP) Food and Drug Administration (FDA) nanotechnology PLGA nanoparticles neurodegenerative diseases drug delivery central nervous system neuroprotective drugs fluorescent labeling DiI coumarin 6 rhodamine 123 Cy5.5 quantum yield brightness stability of fluorescent label confocal microscopy intracellular internalization in vivo neuroimaging double-emulsion method dry powder inhalation antigen release porous PLGA particles microfluidics methotrexate chitosan PLA/PLGA sustained release micro-implant animal model minimally invasive drug delivery system nanoparticles poly (lactic-co-glycolic acid) (PLGA) microfluidic pharmacokinetics (PK) and biodistribution atorvastatin calcium poly(lactide-co-glycolide) polymeric nanoparticles carrageenan induced inflammation anti-inflammatory radiolabeled nanoparticles nuclear medicine photothermal therapy phthalocyanine SKOVip-kat Katushka TurboFP635 JO-4 PLGA orthotopic tumors 3D culture spheroids poly(lactic-co-glycolic acid) nanomedicine scale-up manufacturing clinical translation inline sonication tangential flow filtration lyophilization downstream processing H. pylori design of experiments poly(lactic-co-glycolic) acid size cancer chemoimmunotherapy immunogenic cell death immune checkpoint blockade PNA5 glycopeptide mas receptor angiotensin PLGA diblock copolymer ester and acid-end capped double emulsion solvent evaporation biocompatible biodegradable cardiovascular nanoparticle solid-state characterization in vitro drug release kinetics modeling PEGylation amine emulsion polyvinyl alcohol (PVA) Pluronic triblock copolymer trehalose sucrose Indomethacin solvents stabilizers morphology particle-size encapsulation drug release cytotoxicity |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease |
Record Nr. | UNINA-9910580215803321 |
Tagit Oya | ||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pheochromocytoma (PHEO) and Paraganglioma (PGL) |
Autore | Pacak Karel |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
Descrizione fisica | 1 electronic resource (380 p.) |
Soggetto non controllato |
polycythemia
peptide receptor radiotherapy vasculogenesis catecholamines neuroendocrine GTV adaptive immunity therapy resistance histology transgenic mice cryoablation spheroids energy metabolism somatostatinoma angiogenesis pheochromocytoma SDHD percutaneous ethanol injection metanephrines SDHB global longitudinal strain mutation normetanephrines catecholamine PASS PGL 177Lu-DOTATATE chromosomal alteration speckle-tracking echocardiography lL-6 dog percutaneous ablation stem-like tumor cells EPAS1 neural crest fluorescence imaging neutrophil xenograft inflammation head and neck weighted standard deviation FGF21 calorimetry HIF average real variability next-generation sequencing adrenocortical carcinoma carotid body hypoxia-inducible factor paraganglioma succinate dehydrogenase blood pressure variability arrhythmia mortality NF1 toll-like receptor GAPP NET subclinical systolic dysfunction pheochromocytoma and paraganglioma PET-CT pan-cancer analysis mouse pheochromocytoma cells innate immunity neurogenesis neuroendocrine tumor obesity hypotension hypoxia CNV detection 18F-FDOPA comparative genomics adrenomedullary function PCC pathogen-associated molecular patterns adrenal tumor radiotherapy 11C-hydroxy-ephedrine radiofrequency ablation PPGL minimally invasive procedure sporadic diabetes mellitus adrenal incidentaloma germline mutation immunotherapy VHL immunohistochemistry metastatic OR malignant pheochromocytoma erythropoietin postoperative targeted therapy PRRT metastatic mitochondria T cell TCA cycle meta-analysis pseudohypoxia ectopic secretion radiosensitization chromogranin A hereditary hypertension PET phosphorylation tyrosine hydroxylase |
ISBN | 3-03921-655-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Pheochromocytoma |
Record Nr. | UNINA-9910367743903321 |
Pacak Karel | ||
MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|